Long-term protection against diphtheria in the Netherlands after 50 years of vaccination: Results from a seroepidemiological study

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Swart, E M ^a   Van Gageldonk, P G M ^a   De Melker, H E ^a   Van Der Klis, F R ^a   Berbers, G A M ^a   Mollema, L ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA ANTIBODY; DIPHTHERIA VACCINE; IMMUNOGLOBULIN G ANTIBODY; DIPHTHERIA TOXOID; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD BANK; BLOOD EXAMINATION; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DIPHTHERIA; EASTERN ORTHODOXY; FEMALE; HUMAN; IMMUNIZATION; IMMUNOASSAY; IMMUNOSURVEILLANCE; INFANT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NETHERLANDS; NEWBORN; POPULATION RESEARCH; PRESCHOOL CHILD; PROTESTANT; REFERENCE VALUE; REVACCINATION; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEROPREVALENCE; VACCINATION; YOUNG ADULT; BLOOD; CORYNEBACTERIUM DIPHTHERIAE; CROSS-SECTIONAL STUDY; IMMUNOLOGY; MICROBIOLOGY; PATIENT ATTITUDE; PREVENTIVE HEALTH SERVICE; PROTESTANTISM; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CORYNEBACTERIUM DIPHTHERIAE; CROSS-SECTIONAL STUDIES; DIPHTHERIA; DIPHTHERIA ANTITOXIN; DIPHTHERIA TOXOID; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NETHERLANDS; PATIENT ACCEPTANCE OF HEALTH CARE; PROTESTANTISM; SEROEPIDEMIOLOGIC STUDIES; TIME FACTORS; VACCINATION;

EID: 84959432297     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148605     Document Type: Article

References (39)

1. World Health Organization Immunization surveillance, assessment and monitoring-Global and regional data and statistics.
2. Dittmann S, Wharton M, Vitek C, Ciotti M, Galazka A, et al. (2000) Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned. J Infect Dis 181 Suppl 1: S10-22. PMID: 10657185
3. Hardy IR, Dittmann S, Sutter RW (1996) Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. Lancet 347: 1739-1744. PMID: 8656909
4. Galazka A (2000) The changing epidemiology of diphtheria in the vaccine era. J Infect Dis 181 Suppl 1: S2-9. PMID: 10657184
5. Statistics Netherlands Gezondheid, leefstijl, zorggebruik en -aanbod, doodsoorzaken; vanaf 1900.
6. European Centre for Disease Prevention and Control (2015) A case of diphtheria in Spain. 8.
7. Wagner KS, Stickings P, White JM, Neal S, Crowcroft NS, et al. (2009) A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use. Vaccine 28: 14-20. doi: 10.1016/j.vaccine.2009.09.094 PMID: 19818425
8. Both L, White J, Mandal S, Efstratiou A (2014) Access to diphtheria antitoxin for therapy and diagnostics. Euro Surveill 19.
9. Neal S, Efstratiou A (2007) DIPNET-establishment of a dedicated surveillance network for diphtheria in Europe. Euro Surveill 12: E9-E10.
10. Schurink-van 't Klooster TM, Melker HE (2015) The National Immunisation Programme in the Netherlands. Surveillance and developments in 2014-2015. Bilthoven: National Institute for Public Health and the Environment [in Dutch: RIVM] RIVM Report 2015-0134 RIVM Report 2015-0134.
11. Health Council of the Netherlands (2004) Vaccination against pertussis. The Hague: Health Council of the Netherlands.
12. van Lier EA, Oomen PJ, Giesbers H, Conyn-van Spaendonck MAE, Drijfhout IH, et al. (2014) Immunisation coverage National Immunisation Programme in the Netherlands [in Dutch]. Bilthoven, the Netherlands: National Institute for Public Health and the Environment [in Dutch: RIVM]. RIVM rapport 150202003/2014 RIVM rapport 150202003/2014.
13. Ruijs WL, Hautvast JL, van Ansem WJ, Akkermans RP, van't Spijker K, et al. (2012) Measuring vaccination coverage in a hard to reach minority. Eur J Public Health 22: 359-364. doi: 10.1093/eurpub/ckr081 PMID: 21715468
14. de Melker HE, Berbers GA, Nagelkerke NJ, Conyn-van Spaendonck MA (1999) Diphtheria antitoxin levels in the Netherlands: a population-based study. Emerg Infect Dis 5: 694-700. PMID: 10511526
15. van der Klis FRM, Mollema L, Berbers GA, de Melker HE, Coutinho RA (2009) Second national serum bank for population-based seroprevalence studies in the Netherlands. Neth J Med 67: 301-308. PMID: 19687529
16. Mollema L, Melker HE, Hahne SJM, Weert JWM, Berbers GAM, et al. (2009) PIENTER 2-project: second research project on the protection against infectious diseases offered by the national immunization programme in the Netherlands. Bilthoven, the Netherlands: National Institute for Public Health and the Environment [in Dutch: RIVM].
17. van Gageldonk PG, von Hunolstein C, van der Klis FR, Berbers GA (2011) Improved specificity of a multiplex immunoassay for quantitation of anti-diphtheria toxin antibodies with the use of diphtheria toxoid. Clin Vaccine Immunol 18: 1183-1186. doi: 10.1128/CVI.05081-11 PMID: 21613460
18. Scheifele DW, Ochnio JJ (2009) The Immunological Basis for Immunization Series. Module 2: Diphtheria Update 2009. Geneva: World Health Organization.
19. De Melker HE, Conyn-van Spaendonck MA (1998) Immunosurveillance and the evaluation of national immunization programmes: a population-based approach. Epidemiol Infect 121: 637-643. PMID: 10030714
20. van den Hof S, Melker HE, Suijkerbuijk AWM, Conyn-van Spaendonck MAE (1997) Pienter project: description of serumbank and information on participants from the questionnaires. Bilthoven, the Netherlands: National Institute for Public Health and the Environment [in Dutch: RIVM]. 213675005 213675005.
21. Hendriksen CFM, van der Gun JW, Kreeftenberg JG (1989) Combined estimation of tetanus and diphtheria antitoxin in human sera by the in vitro Toxin-Binding Inhibition (ToBI) test. Journal of Biological Standardization 17: 191-2000. PMID: 2715153
22. R Core Team (2013) R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
23. Stastistics Netherlands Population on 1 January 2007.
24. Bickel PJ, Doksum KA (2001) Mathematical Statistics: Basic Ideas and Selected Topics. London: Prentice-Hall.
25. Wagner KS, White JM, Andrews NJ, Borrow R, Stanford E, et al. (2012) Immunity to tetanus and diphtheria in the UK in 2009. Vaccine 30: 7111-7117. doi: 10.1016/j.vaccine.2012.09.029 PMID: 23022148
26. Zasada AA, Rastawicki W, Rokosz N, Jagielski M (2013) Seroprevalence of diphtheria toxoid IgG antibodies in children, adolescents and adults in Poland. BMC Infect Dis 13: 551. doi: 10.1186/1471-2334-13-551 PMID: 24252165
27. di Giovine P, Kafatos G, Nardone A, Andrews N, Olander RM, et al. (2013) Comparative seroepidemiology of diphtheria in six European countries and Israel. Epidemiol Infect 141: 132-142. doi: 10.1017/S0950268812000210 PMID: 22361223
28. Olander RM, Auranen K, Harkanen T, Leino T (2009) High tetanus and diphtheria antitoxin concentrations in Finnish adults-time for new booster recommendations? Vaccine 27: 5295-5298. doi: 10.1016/j.vaccine.2009.06.080 PMID: 19596410
29. Booy R, Aitken SJ, Taylor S, Tudor-Williams G, Macfarlane JA, et al. (1992) Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet 339: 507-510. PMID: 1346876
30. Ramsay ME, Rao M, Begg NT, Redhead K, Attwell AM (1993) Antibody response to accelerated immunisation with diphtheria, tetanus, pertussis vaccine. Lancet 342: 203-205. PMID: 8100929
31. Spijkerman J, Veenhoven RH, Wijmenga-Monsuur AJ, Elberse KE, van Gageldonk PG, et al. (2013) Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial. JAMA 310: 930-937. doi: 10.1001/jama.2013.228052 PMID: 24002279
32. Miller E, Ashworth LA, Redhead K, Thornton C, Waight PA, et al. (1997) Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance. Vaccine 15: 51-60. PMID: 9041666
33. Pichichero ME, Badgett JT, Rodgers GC Jr, McLinn S, Trevino-Scatterday B, et al. (1987) Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children. Pediatr Infect Dis J 6: 352-363. PMID: 3495775
34. Burgmeijer R, Hoppenbrouwers K (2011) Handboek vaccinaties Deel A Theorie en uitvoeringspraktijk. Assen: Van Gorcum. 574 p.
35. Volzke H, Kloker KM, Kramer A, Guertler L, Doren M, et al. (2006) Susceptibility to diphtheria in adults: prevalence and relationship to gender and social variables. Clin Microbiol Infect 12: 961-967. PMID: 16961631
36. Kurugol Z, Midyat L, Turkoglu E, Isler A (2011) Immunity against diphtheria among children and adults in Izmir, Turkey. Vaccine 29: 4341-4344. doi: 10.1016/j.vaccine.2011.04.016 PMID: 21510994
37. Schurink-van 't Klooster TM, Melker HE (2014) The National Immunisation Programme in the Netherlands. Developments in 2013. Bilthoven: National Institute for Public Health and the Environment [in Dutch: RIVM] RIVM Report 150202002/2013 RIVM Report 150202002/2013.
38. Di Giovine P, Pinto A, Olander RM, Sesardic D, Stickings P, et al. (2010) External quality assessment for the determination of diphtheria antitoxin in human serum. Clin Vaccine Immunol 17: 1282-1290. doi: 10.1128/CVI.00096-10 PMID: 20610661
39. von Hunolstein C, Ralli L, Pinto A, Stickings P, Efstratiou A, et al. (2014) Relevance and Criticality in an External Quality Assessment for the Determination of Diphtheria Antitoxin. J Immunol Clin Res 2: 1022.